Inovio Pharmaceuticals Inc. Stock Rallies 8.3%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rallied 8.3% to $1.30 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.

This was the stock's eighth consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 56.4% short of its 52-week high of $2.98, which the company reached on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Statera Biopharma Inc. fell 50.0% to $0.00, and Pfizer Inc. rose 3.63% to $28.24.

Trading volume totaled 6.8 million, compared to the 50-day average of 3.3 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 19, 2026 16:33 ET (20:33 GMT)